
Oncology Today with Dr Neil Love: Management of HER2-Altered Non-Small Cell Lung Cancer?
Lung Cancer Update
00:00
ILD in Lung Cancer?
In breast cancer, the approach is if you pick it up when it's safe symptomatic, then theoretically you can re-challenge. Is that algorithm applied to lung cancer? Yeah, generally that's the same algorithm that we're using across the Destiny trials. The other issue is imaging. So again, the breast people right now are saying we're trying to get imaging every eight or nine weeks and maybe for a long time. But in standard practice, I think it has to be a bit more personalized.
Transcript
Play full episode